Federal Supply Schedule 36F79721D0104
Award Date
3/1/21
Last Date to Order
2/28/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Q Biomed Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to acquire pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. Circassia Inc. was awarded the IDV with a potential value of $30.4 million and a period of performance through March 2025. The IDV facilitates the acquisition of drugs, pharmaceuticals, and hematology-related products through task orders or delivery orders issued...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. West Therapeutic Development, LLC was awarded the IDV as the prime contractor. The IDV aims to procure a range of drugs, pharmaceuticals, and hematology-related products over a four year period ending in January 2024, with a potential value of $225,000. No set-asides were...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. The prime contractor is Akorn, Inc. With a potential value of $244,163,640 and a period of performance through June 2023, the IDV aims to facilitate orders for Schedule 65 IB products including drugs, pharmaceuticals, and hematology-related items to support VA...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. The contract aims to procure various drugs, pharmaceuticals, and hematology-related products through May 2023. Baudax Bio, Inc. is the prime contractor with a potential value of $620,400. The original solicitation sought drugs, pharmaceuticals, and related products to support the treatment of...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to acquire pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. The contract aims to procure a range of drugs, pharmaceuticals, and hematology-related products for $225,000 over its June 2021 to December 2021 period of performance. Oncopeptides, Inc. is the prime contractor tasked with delivering these products and services under...
The federal contract IDV award is a Federal Supply Schedule contract with the Department of Veterans Affairs to provide pharmaceutical and hematology-related products. The 5-year, $250,000 multiple award IDV enables VA medical centers in Veterans Integrated Service Network 12 to procure hematology products without separate solicitations. The prime contractor is 60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and commercializes infectious disease medicines. 60...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. Hill Dermaceuticals Inc. was awarded the IDV with a potential value of $225,000. No set-aside was used. Products and services must be delivered by January 14, 2023. The IDV aims to procure drugs, pharmaceuticals, and hematology-related products listed in GSA Schedule 65...
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Therapeuticsmd, Inc. for the provision of pharmaceuticals, drugs, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. This multiple-award contract has a potential value of $250,000.00 and a period of performance from May 15, 2020 to May 15, 2024. Therapeuticsmd, Inc.,...
The federal contract IDV award is for pharmaceuticals and drugs under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. The multiple award IDV was granted by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Rockwell Medical, Inc. on March 1, 2021, with a potential value of $250,000 and period of performance through December 15, 2022. The IDV facilitates delivery of drugs, pharmaceuticals, and hematology-related products to...